Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 1/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.64 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.64 |
| ▸ | HTT | P42858 | 1/20 | 0.57 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
| ▸ | TSHR | P16473 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.55 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | SCN1A | P35498 | 1/20 | 0.51 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.51 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29975597 | 1.00 | FOLH1 (0.66) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| Hydrochloric Acid SCHEMBL7699238 | 0.98 | FOLH1 (0.63) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| SCHEMBL8702953 | 0.98 | FOLH1 (0.63) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| SCHEMBL8698803 | 0.93 | FOLH1 (0.58) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| SCHEMBL70392 | 0.91 | FOLH1 (0.76) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| SCHEMBL30365583 | 0.91 | FOLH1 (0.76) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| SCHEMBL7764255 | 0.89 | TSHR (0.72) | FOLH1ALDH1A1ADRB2HTTMAPT | |
| SCHEMBL11710027 | 0.88 | FOLH1 (0.61) | FOLH1ALDH1A1ADRB2MAPTTSHR | |
| SCHEMBL20162476 | 0.88 | FOLH1 (0.61) | FOLH1ALDH1A1ADRB2MAPTTSHR | |
| Hydrochloric Acid SCHEMBL8327538 | 0.88 | KMT2A (0.56) | FOLH1ALDH1A1ADRB2HTTMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 887 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4568640-B1 | SUNSCREEN COMPOSITION | DSM IP ASSETS BV (NL) | 2026-05-13 | — | — | EP | claimed |
| EP-4340804-B1 | SUNSCREEN COMPOSITION COMPRISING BEMOTRIZINOL | DSM IP ASSETS BV (NL) | 2026-02-04 | — | — | EP | claimed |
| EP-4661890-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | Purdue Research Foundation (US) | 2025-12-17 | — | — | EP | claimed |
| EP-3695826-B1 | USE OF SODA-LIME-BOROSILICATE IN A COSMETIC COMPOSITION TO REDUCE ADHESION OF SAND ON THE SKIN | BEIERSDORF AG (DE) | 2025-10-29 | — | — | EP | claimed |
| EP-4251121-B1 | TOPICAL COMPOSITION | DSM IP ASSETS BV (NL) | 2025-10-01 | — | — | EP | claimed |
| EP-4016044-B1 | IMPROVED METHOD FOR OPTICALLY CLARIFYING A TISSUE SAMPLE FOR MICROSCOPIC EXAMINATION | MobiCron GmbH (DE) | 2025-02-05 | — | — | EP | claimed |
| EP-3689849-B1 | PERFUME PRECURSOR | TAKASAGO PERFUMERY CO LTD (JP) | 2025-01-15 | — | — | EP | claimed |
| WO-2024167565-A1 | PTP1B/TC-PTP DUAL INHIBITORS AND PROTEIN DEGRADERS | PURDUE RESEARCH FOUNDATION (US) | 2024-08-15 | — | — | WO | claimed |
| EP-4256010-B1 | COMPOSITION | UNILEVER IP HOLDINGS B V (NL) | 2024-07-17 | — | — | EP | claimed |
| CN-118184679-A | Photothermal agent and preparation method thereof, photothermal nanoparticle and preparation method thereof, insulating material and self-repairing method of insulating material | 中国石油天然气股份有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-6809119-B2 | FOR USE AS AS NEURO-PROTECTIVE AGENTS FOR THERAPY OF CONDITIONS SUCH AS STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMINOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE | WARNER-LAMBERT COMPANY LLC | 2004-10-26 | — | — | US | claimed |
| US-20030149110-A1 | Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases | HU LAIN-YEN (US) | 2003-08-07 | — | — | US | claimed |
| WO-2003045902-A1 | BRANCHED CHAIN AMINO ACID-DEPENDENT AMINOTRANSFERASE INHIBITORS AND THEIR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES | WARNER-LAMBERT COMPANY LLC (US) | 2003-06-05 | — | — | WO | claimed |
| EP-1314723-A1 | Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases | WARNER-LAMBERT COMPANY (US) | 2003-05-28 | — | — | EP | claimed |
| EP-0787176-B1 | FABRIC SOFTENER COMPOSITIONS WITH REDUCED ENVIRONMENTAL IMPACT | PROCTER & GAMBLE (US) | 2003-05-07 | — | — | EP | claimed |
| US-6398857-B1 | ACCUSTIC PIEZOELECTRIC; HOT MELT INK JET PRINTING; BENZOIC ACID VEHICLE; ALKYL OR PHENYL CARBOXYLIC ACID VISCOSITY MODIFIER; RETAINS DESIRED HARDNESS | XEROX CORPORATION | 2002-06-04 | — | — | US | claimed |
| EP-0727698-B1 | Photographic silver halide element having polyester support and exhibiting improved wet adhesion | EASTMAN KODAK CO (US) | 2000-07-26 | — | — | EP | claimed |
| US-5834175-A | PHENOLIC COMPOUND | EASTMAN KODAK COMPANY (US) | 1998-11-10 | — | — | US | claimed |
| US-5726003-A | Cyan coupler dispersion with increased activity | EASTMAN KODAK COMPANY (US) | 1998-03-10 | — | — | US | claimed |
| US-4560787-A | CYCLOCONDENSATION, ACID CATALYSTS, TRICHLOROMETHYL BENZENE | DYNAMIT NOBEL AG (DE) | 1985-12-24 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030149110-A1 | Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases | BCAT1, BCAT2, ABAT | FOLH1 703/4885ALDH1A1 812/4885ADRB2 475/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.